Analysis of the association between vitamin D and viral infections and risk factors related to Covid-19
DOI:
https://doi.org/10.33448/rsd-v9i8.5161Keywords:
Vitamin D; Coronavírus infections; Respiratory infection.Abstract
At the end of 2019, a new virus emerged in Wuhan, China, there was an unrestrained spread in several countries, until the World Health Organization declared a pandemic state, and the changes that are causing it all over the world have been the subject of constant concern. by health professionals. Coronavirus mortality has already reached more than 4%, and although there are numerous researches in progress, trials based on the hypothesis of vaccine formulation, there is still no effective and safe treatment, patients with COVID-19 have an inflammatory state especially in interleukins. It is an integrative review, based on the publications contained in the PUBMED and SCIELO.ORG databases, with articles in the timeline of the first 5 months of the year 2020, all articles were found using the combinations of the following descriptors arranged in DECs: COVID-19, infections, Vitamin D, infection and Vitamin D, in English, Portuguese and Spanish. Several studies point to the actions of vitamin D in reducing inflammatory microbial activities, and it helps to increase immunity by decreasing cytokine activity. Vitamin D deficiency has been identified as one of the protective factors for the risk of COVID-19, since the receptors for this vitamin are widely distributed in the respiratory tract, since vitamin D activation is driven by stimulation processes, Adequate concentrations of 25 (OH) D is important to avoid complications and viral replications in the body.
References
Caccialanza, R., Laviano Alessandro, L. F., Montagna, E., Bruno, R., Ludovini, S., Corsico, A. G., Sabatino, A. D., Belliato, M., Calvi, M., Lacona, I., Grugnetti, G., Bonadeo, E., Muzzi, A., & Cereda, E. (2020). Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19): rationale and feasibility of a shared pragmatic protocol. Nutrition. 74. 2020. https://doi.org/10.1016/j.nut.2020.110835.
Ebadi, M., Montano-Loza, A. J. (2020). Perspective: improving vitamin D status in the management of COVID-19. European Journal of clinical nutrition. 12, 1-4. https://doi.org/ 10.1038/s41430-020-0661-0.
Grant, W. B., Lahore H., McDonnell, S. L., Baggerly, C. A., French, C. B., Aliano, J. L., Bhattoa, & Harjit, P. (2020). Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients. 12(988). https://doi.org/ 10.3390/nu12040988.
Hastie, C. E., Mackay, D. F., Hoo, F., Celis-Morales, C., Katikireddi, S, V,, Niedzwiedz, C, L., Jani, B. D., Welsh, P., Mair, F. S., Gray, S. R., O'Donnell, C, A., Gill, J. Mr., Sattar, N., & Pell, J. P. (2020). Vitamin D concetrations and COVID-19 infection in UK Biobank. Diabetes & Metabolic syndrome: clinical Research & reviews. Doi: https://doi.org/10.1016/j.dsx.2020.04.050.
Hrisbar C., Cobbold, P. H., & Church, F. C.. (2020). Potential role of vitamin D in the elderly to resist COVID-19 and to slow progression of Parkinson’s disease. Brain Scienses, 10(5), 284. https://doi.org/10.3390/brainsci10050284.
Ilie, P. C., Stefanescu, S., & Smith, L. (2020). The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality. Aging Clinical and experimental research. Doi: https://doi.org/10.1007/s40520-020-01570-8.
Jakovac, H. (2020). COVID-19 and vitamin D – Is there a link and na opportunity for intervention? American Journal of physiology endocrinology and metabolism. 318(5), 589. https://doi.org/ 10.1152/ajpendo.00138.2020.
Kakodkar, P., Kaka, N., & Baing, M. N. (2020). A comprehensive literature review on the clinical presentation, and management of the pandemic coronavirus disease 2019 (COVID-19). Cureus. 12 (4), https://doi.org/10.7759/cureus.7560.
Marik, P. E., Kory, P., & Varon, J. (2020). Does vitamin D status impact mortality from SARS-Cov-2 infection? Medicine in drug Discovery. Doi: https://doi.org/10.1016/j.medidd.2020.100041.
Misra, D., Prasanna, A, V., Gasparyan, A. Y., & Zimba, O. (2020). Rheumatologist’s perspective on coronavirus disease 19 (COVID-19) and potential therapeutics targets. Perspectives in rheumatology. Doi: https://doi.org/10.1007/s10067-020-05073-9.
Silberstein, M. Vitamin D: a simpler alternative to tocilizumab for trial in COVID-19? Medical Hypotheses. Doi: https://doi.org/10.1016/j.mehy.2020.109767.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
